CD93 is a transmembrane glycoprotein, which is predominantly expressed in AML blasts and LSCs, but is absent in healthy HSCs (73).Importantly, CD93 expression is relatively stable and highly expressed in a significant proportion of relapsed AML patients. The gene discussed is CD93; the disease is acute myeloid leukemia.